Showing results (2221-2230 of 2,319) with videos related to

Sort By:
Pageof 232
JAMA Internal Medicine|March 2, 2026
Diacerein for Knee Osteoarthritis: A Randomized Clinical TrialDawn Aitken, Guoqi Cai, Catherine L Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasisMargaret M Mentink-Kane, Allen W Cheever, Robert W Thompson, et al.
Breast Cancer Research : BCR|November 29, 2013
Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cellsHonor J Hugo, Lloyd Pereira, Randy Suryadinata, et al.
Nature Chemical Biology|February 3, 2026
Functional analysis of O-GlcNAcylation by networking of OGT interactors and substratesMatthew E Griffin, John W Thompson, Yao Xiao, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 12, 2000
Measuring contributions to the clinical mission of medical schools and teaching hospitalsR M D'Alessandri, P Albertsen, B F Atkinson, et al.
Microbiology Resource Announcements|March 28, 2022
Complete Genome Sequences of Five Bacteriophages That Infect Enterobacteriales HostsSeth Evans, Hunter Cobbley, Kye Davis, et al.
Theranostics|April 11, 2022
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entryPeiyu Wang, Renwu Zhou, Rusen Zhou, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 17, 2011
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primatesI R Badell, P W Thompson, A P Turner, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
Redox Biology|December 5, 2023
Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated mediumPeiyu Wang, Renwu Zhou, Rusen Zhou, et al.
Pageof 232